Alnylam Pharmaceuticals Inc (ALNY)
143.16
-0.64
(-0.45%)
USD |
NASDAQ |
Apr 25, 10:27
Alnylam Pharmaceuticals Market Cap: 18.03B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 18.11B |
| April 23, 2024 | 18.40B |
| April 22, 2024 | 18.36B |
| April 19, 2024 | 18.19B |
| April 18, 2024 | 18.28B |
| April 17, 2024 | 18.30B |
| April 16, 2024 | 18.48B |
| April 15, 2024 | 18.60B |
| April 12, 2024 | 18.70B |
| April 11, 2024 | 19.16B |
| April 10, 2024 | 19.20B |
| April 09, 2024 | 19.63B |
| April 08, 2024 | 19.65B |
| April 05, 2024 | 19.34B |
| April 04, 2024 | 19.08B |
| April 03, 2024 | 19.00B |
| April 02, 2024 | 19.02B |
| April 01, 2024 | 19.31B |
| March 28, 2024 | 18.82B |
| March 27, 2024 | 19.44B |
| March 26, 2024 | 19.14B |
| March 25, 2024 | 19.15B |
| March 22, 2024 | 18.45B |
| March 21, 2024 | 18.47B |
| March 20, 2024 | 18.64B |
| Date | Value |
|---|---|
| March 19, 2024 | 18.66B |
| March 18, 2024 | 18.57B |
| March 15, 2024 | 18.80B |
| March 14, 2024 | 18.71B |
| March 13, 2024 | 18.69B |
| March 12, 2024 | 18.47B |
| March 11, 2024 | 18.78B |
| March 08, 2024 | 18.87B |
| March 07, 2024 | 18.87B |
| March 06, 2024 | 18.85B |
| March 05, 2024 | 18.85B |
| March 04, 2024 | 18.90B |
| March 01, 2024 | 19.22B |
| February 29, 2024 | 19.03B |
| February 28, 2024 | 19.55B |
| February 27, 2024 | 20.03B |
| February 26, 2024 | 19.98B |
| February 23, 2024 | 19.86B |
| February 22, 2024 | 20.51B |
| February 21, 2024 | 19.49B |
| February 20, 2024 | 18.85B |
| February 16, 2024 | 18.51B |
| February 15, 2024 | 18.57B |
| February 14, 2024 | 20.67B |
| February 13, 2024 | 20.40B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.017B
Minimum
May 20 2019
29.69B
Maximum
Dec 21 2022
18.58B
Average
18.51B
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals Inc | 6.138B |
| Pfizer Inc | 144.95B |
| Blueprint Medicines Corp | 5.549B |
| Madrigal Pharmaceuticals Inc | 3.864B |
| Sarepta Therapeutics Inc | 11.59B |
Market Cap Related Metrics
| PS Ratio | 9.900 |
| Price to Free Cash Flow | 431.52 |
| Price | 143.16 |
| Earnings Yield | -2.49% |